The Actavis Group is represented in Poland by the following two entities:

• Actavis Polska – marketing and promotion
• Biovena Pharma – production and distribution

The Actavis Group has a wide portfolio of modern pharmaceuticals, which are used mainly in the treatment of urological, psychiatric, neurological, cardiological, dermatological, laryngological, muscular-skeletal and oncological diseases. 

56 products are marketed and 24 new product launches are planned for 2012 on the Polish market.

In total, more than 350 people are working for the Actavis Group in Poland.

Contact information:

Actavis Polska Sp. z o.o.
ul. Marynarska 15
02-674 Warszawa
Poland

Tel.: +48225122900
Fax.: +48225122997
Managing Director: Izabela Zimmermann

E-mail: biuro@actavis.com  

Biovena Pharma Sp. z o.o. 
ul. Marynarska 15
02-674 Warszawa
Poland

Tel.: +48225122900
Fax.: +48225122997
E-mail: biuro@actavis.com